Plexision
Business Services · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4424 Penn Ave Ste 202, Pittsburgh, Penns...Phone Number
(855) 753-9474Website
www.plexision.comRevenue
<$5 MillionIndustry
About Plexision
Plexision is a biotechnology company specializing in the development of cellular biomarkers for personalized diagnostics and drug development, particularly in solid organ transplantation and immunological disorders. Their product offerings include a range of FDA-approved blood tests that predict the risk of transplant rejection and assess cellular immunity to various viral infections, including COVID-19. The company also engages in custom R&D projects aimed at integrating biomarker targets throughout all phases of drug development. Plexision's state-of-the-art laboratory is located in Pittsburgh, PA, and is CLIA-certified.Explore more
Plexision Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Plexision
Compare insights from companies similar to Plexision, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Plexision
<$5M
1-10
Private
<$5M
2008
RS
Rakesh SindhiCo-Founder & Scientific Chief & Officer & CEO & Member of Board of Directors
Plexision Tech Stack
A closer look at the technologies used by Plexision
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Plexision
Sign Up For FreeTo access detailed company insights
Plexision is a biotechnology company specializing in the development of cellular biomarkers for personalized diagnostics and drug development, particularly in solid organ transplantation and immunological disorders. Their product offerings include a range of FDA-approved blood tests that predict the risk of transplant rejection and assess cellular... Read More
